19 December 2011
Cardiac resynchronisation therapy (CRT) could have substantial benefits for those with heart problems, a new clinical trial has found.
According to the European CRT Survey, which published a follow-up study to find out how influential the therapy was on patients with cardiac troubles, CRT is now cited in the European and American guidelines for the treatment of heart failure.
The survey by the Heart Failure Association and European Heart Rhythm Association of the European Society of Cardiology gained information on more than 2,000 patients at 141 centres in 13 European countries and looked at how their symptoms and rates of survival had improved after CRT.
Author of the most recent study Dr Nigussie Bogale from Stavanger University Hospital in Norway said: "Most patients with an indication for CRT have also an indication for a defibrillator. So unless they have contraindicating co-morbidities, it is now our belief that these patients should be considered for CRT-D [cardiac resynchronisation therapy with a defibrillator] implantation."
A previous study published in MedScape Today suggested that defibrillation testing at the end of the implantation of CRT-D exposes heart failure patients to increased risks during routine procedures.
Posted by Philip Briggs
Bogale N, et al., "The European CRT Survey: 1 year (9-15 months) follow-up results.", European Journal Heart Failure 2011.
Maurizio Gasparini, et al., "Delayed Defibrillation Testing in Patients Implanted with Biventricular ICD (CRT-D)A Reliable and Safe Approach", MedScape Today, 2006.
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.